|
FR1311316A
(fr)
|
1961-04-12 |
1962-12-07 |
Science Union Et Compagnie Soc |
Nouveaux dérivés de la pipérazine et leurs préparations
|
|
NL127996C
(enExample)
|
1963-11-19 |
|
|
|
|
US3485757A
(en)
|
1964-11-23 |
1969-12-23 |
Atomic Energy Commission |
Thermoelectric composition comprising doped bismuth telluride,silicon and boron
|
|
DE1595923A1
(de)
*
|
1965-02-20 |
1969-11-27 |
Merck Ag E |
1-Aralkyl-4-(thiazolyl-2)-piperazine und Verfahren zu ihrer Herstellung
|
|
GB1165283A
(en)
|
1967-01-17 |
1969-09-24 |
Science Union & Cie |
New Purine Derivatives and processes for prepararing them
|
|
US4600025A
(en)
|
1982-11-18 |
1986-07-15 |
Grigg Ronald E |
Smoking products comprising nicotine substitutes
|
|
AU675786B2
(en)
|
1992-04-15 |
1997-02-20 |
Merck Sharp & Dohme Limited |
Azacyclic compounds
|
|
IL118768A
(en)
|
1995-07-12 |
2000-10-31 |
Akzo Nobel Nv |
Diphenylmethane piperidine derivatives pharmaceutical compositions containing them and a method for their preparation
|
|
TW504510B
(en)
|
1996-05-10 |
2002-10-01 |
Janssen Pharmaceutica Nv |
2,4-diaminopyrimidine derivatives
|
|
US6534496B1
(en)
|
1997-04-17 |
2003-03-18 |
Takeda Chemical Industries, Inc. |
Thermogenic composition and benzazepine thermogenics
|
|
AU9810498A
(en)
|
1997-10-24 |
1999-05-17 |
Neurogen Corporation |
1-(2-naphthyl) and 1-(2-azanaphthyl)-4 -(1-phenylmethyl)piperazines being dopamine d4 receptor subtyp e ligands
|
|
BR0209932A
(pt)
*
|
2001-05-22 |
2004-10-13 |
Neurogen Corp |
Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, preparação farmacêutica embalada, métodos para modular ligação de mch a um receptor de mch e de mvc, para alterar a atividade de transdução de sinal de um receptor de mch em uma célula, para tratar uma doença ou distúrbio associado com a ativação de receptor de mch patogênico obesidade e para determinar a presença ou ausência de receptor de mch em uma amostra, e, uso de um composto
|
|
US6982259B2
(en)
|
2002-04-30 |
2006-01-03 |
Schering Aktiengesellschaft |
N-heterocyclic derivatives as NOS inhibitors
|
|
WO2003106452A2
(en)
|
2002-06-12 |
2003-12-24 |
Millennium Pharmaceuticals, Inc. |
Antagonists of melanin concentrating hormone receptor
|
|
CA2744893A1
(en)
|
2002-06-27 |
2004-01-08 |
Novo Nordisk A/S |
Aryl carbonyl derivatives as glucokinase activators
|
|
PT1519939E
(pt)
|
2002-07-05 |
2010-02-10 |
Targacept Inc |
Compostos n-arildiazaspirocíclicos e métodos para a sua preparação e utilização
|
|
AU2003268512A1
(en)
|
2002-09-09 |
2004-03-29 |
Janssen Pharmaceutica N.V. |
Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
|
|
JP2006523692A
(ja)
|
2003-04-18 |
2006-10-19 |
イーライ リリー アンド カンパニー |
５−ｈｔ１ｆ作用薬としての（ピペリジニルオキシ）フェニル、（ピペリジニルオキシ）ピリジニル、（ピペリジニルスルファニル）フェニル、および（ピペリジニルスルファニル）ピリジニル化合物
|
|
AU2004241213B2
(en)
|
2003-05-21 |
2009-04-23 |
Banyu Pharmaceutical Co., Ltd. |
2-aminoquinoline derivative
|
|
BRPI0506662B8
(pt)
|
2004-01-06 |
2021-05-25 |
Novo Nordisk As |
compostos ativadores de glucoquinase
|
|
WO2005110982A2
(en)
|
2004-04-07 |
2005-11-24 |
Neurogen Corporation |
Substituted 1-benzyl-4-substituted piperazine analogues
|
|
HU227119B1
(en)
|
2004-07-29 |
2010-07-28 |
Richter Gedeon Nyrt |
Indole and benzimidazole carboxylic acid amide derivatives and pharmaceutical compositions containing them
|
|
HUP0401522A2
(en)
|
2004-07-29 |
2006-04-28 |
Richter Gedeon Vegyeszet |
New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
|
|
AU2006220187B2
(en)
|
2005-03-01 |
2012-11-08 |
Simon Fraser University |
Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
|
|
EP1705177A1
(en)
*
|
2005-03-23 |
2006-09-27 |
Schering Aktiengesellschaft |
N-aryl-sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agents
|
|
TW200724140A
(en)
|
2005-05-27 |
2007-07-01 |
Eisai Co Ltd |
Hydantoin compounds
|
|
JP2009500377A
(ja)
|
2005-07-08 |
2009-01-08 |
ノボ・ノルデイスク・エー／エス |
ジシクロアルキルウレア型グルコキナーゼ活性化剤
|
|
WO2007008541A2
(en)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc. |
Cellular cholesterol absorption modifiers
|
|
WO2007115077A2
(en)
|
2006-03-31 |
2007-10-11 |
Astrazeneca Ab |
Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators
|
|
WO2007135398A1
(en)
|
2006-05-22 |
2007-11-29 |
Astrazeneca Ab |
Indole derivatives
|
|
US20080051387A1
(en)
|
2006-06-09 |
2008-02-28 |
Yuelian Xu |
Tetrahydropyrido[3,4-d]pyrimidines and related analogues
|
|
WO2008012623A1
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
|
EP2057171A4
(en)
|
2006-08-31 |
2010-04-21 |
Univ Fraser Simon |
SELECTIVE GLYCOSIDASE INHIBITORS AND APPLICATIONS THEREOF
|
|
US20100022517A1
(en)
|
2006-12-18 |
2010-01-28 |
Richards Lori A |
Ophthalmic formulation of rho kinase inhibitor compound
|
|
US8148369B2
(en)
|
2007-05-10 |
2012-04-03 |
Janssen Pharmaceutica Nv |
Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
|
|
WO2009011904A1
(en)
|
2007-07-19 |
2009-01-22 |
Renovis, Inc. |
Compounds useful as faah modulators and uses thereof
|
|
WO2009053373A1
(en)
|
2007-10-26 |
2009-04-30 |
Janssen Pharmaceutica Nv |
Quinolinone derivatives as parp inhibitors
|
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
EP2276738A1
(en)
|
2008-04-17 |
2011-01-26 |
Pfizer Inc. |
Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
|
|
WO2009127948A1
(en)
|
2008-04-17 |
2009-10-22 |
Pfizer Inc. |
4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
|
|
US7863291B2
(en)
|
2008-04-23 |
2011-01-04 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
|
AU2009261248A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
|
JP2010065024A
(ja)
|
2008-08-14 |
2010-03-25 |
Ishihara Sangyo Kaisha Ltd |
トリアゾロピリミジン誘導体又はその塩を含有する有害生物防除剤
|
|
WO2010021381A1
(ja)
|
2008-08-22 |
2010-02-25 |
武田薬品工業株式会社 |
縮合複素環誘導体およびその用途
|
|
CA2735269C
(en)
|
2008-08-29 |
2018-10-16 |
Saint Mary's University |
Use of gluconacetobacter with reduced use of nitrogen fertilizer to improve beet crop production
|
|
CN102137841B
(zh)
|
2008-09-02 |
2014-05-14 |
日产化学工业株式会社 |
邻位取代卤代烷基磺酰苯胺衍生物及除草剂
|
|
TW201030007A
(en)
|
2009-02-06 |
2010-08-16 |
Gruenenthal Gmbh |
Substituted spiro-amides as b1r modulators
|
|
CA2754058A1
(en)
|
2009-03-02 |
2010-09-10 |
Sirtris Pharmaceuticals, Inc. |
8-substituted quinolines and related analogs as sirtuin modulators
|
|
US20100240720A1
(en)
|
2009-03-20 |
2010-09-23 |
Burnham Institute For Medical Research |
Allosteric jnk inhibitors
|
|
US20120010186A1
(en)
|
2009-03-23 |
2012-01-12 |
Merck Frosst Canada Ltd. |
Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
JP2010270034A
(ja)
|
2009-05-20 |
2010-12-02 |
Sumitomo Chemical Co Ltd |
アミド化合物並びにその植物病害防除用途
|
|
CA2765678A1
(en)
|
2009-06-22 |
2010-12-29 |
Christopher Blackburn |
Substituted hydroxamic acids and uses thereof
|
|
DE102009049679A1
(de)
|
2009-10-19 |
2011-04-21 |
Merck Patent Gmbh |
Pyrazolopyrimidinderivate
|
|
US9120781B2
(en)
|
2010-05-11 |
2015-09-01 |
Simon Fraser University |
Selective glycosidase inhibitors and uses thereof
|
|
WO2012037298A1
(en)
|
2010-09-17 |
2012-03-22 |
Glaxosmithkline Llc |
Fatty acid synthase inhibitors
|
|
EP2661435B1
(en)
|
2010-11-08 |
2015-08-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
WO2012061927A1
(en)
|
2010-11-08 |
2012-05-18 |
Alectos Therapeutics, Inc. |
Selective glycosidase inhibitors and uses thereof
|
|
WO2012061972A1
(en)
|
2010-11-08 |
2012-05-18 |
Alectos Therapeutics Inc. |
Selective glycosidase inhibitors and uses thereof
|
|
BR112013016179A2
(pt)
|
2010-12-23 |
2018-07-10 |
Alectos Therapeutics Inc |
inibidores seletivos da glicosidase e usos dos mesmos.
|
|
GB201103526D0
(en)
|
2011-03-02 |
2011-04-13 |
Summit Corp Plc |
Selective glycosidase inhibitors and uses thereof
|
|
EP2687507B1
(en)
|
2011-03-14 |
2016-03-09 |
Taisho Pharmaceutical Co., Ltd. |
Nitrogen-containing condensed heterocyclic compound
|
|
US8884023B2
(en)
|
2011-08-25 |
2014-11-11 |
Merck Patent Gmbh |
Pyrano [3,2-D][1,3]thiazole as glycosidase inhibitors
|
|
EP2773207B1
(en)
|
2011-10-31 |
2018-03-07 |
Merck Sharp & Dohme Corp. |
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
|
|
AR092031A1
(es)
|
2012-07-26 |
2015-03-18 |
Merck Sharp & Dohme |
Inhibidores del canal de potasio medular externo renal
|
|
WO2014023723A1
(en)
|
2012-08-08 |
2014-02-13 |
Novartis Ag |
Subtituted azines as pesticides
|
|
EP2890678A4
(en)
|
2012-08-31 |
2016-01-27 |
Alectos Therapeutics Inc |
GLYCOSIDASE INHIBITORS AND USES THEREOF
|
|
WO2014159234A1
(en)
|
2013-03-14 |
2014-10-02 |
Merck Patent Gmbh |
Glycosidase inhibitors
|
|
CN103435606A
(zh)
|
2013-08-22 |
2013-12-11 |
中国药科大学 |
CDK2与GSK3β双重抑制剂及用途
|
|
LT3077395T
(lt)
|
2013-12-05 |
2018-02-12 |
Pfizer Inc. |
Pirolo[2,3-d]pirimidinilo, pirolo[2,3-b]pirazinilo ir pirolo[2,3-d]piridinilo akrilamidai
|
|
EP2913330A1
(en)
|
2014-02-27 |
2015-09-02 |
Laboratoire Biodim |
Condensed derivatives of imidazole useful as pharmaceuticals
|
|
EP3134413B1
(en)
|
2014-04-23 |
2019-09-11 |
Dart NeuroScience (Cayman) Ltd. |
Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitors
|
|
AR101197A1
(es)
*
|
2014-07-16 |
2016-11-30 |
Gruenenthal Gmbh |
Pirimidinas 2,5-sustituidas
|
|
MX381417B
(es)
|
2014-08-28 |
2025-03-12 |
Asceneuron Sa |
Inhibidores de glucosidasa.
|
|
EA035544B1
(ru)
*
|
2014-10-08 |
2020-07-03 |
Юсб Байофарма Спрл |
Производные тетрагидроизохинолина
|
|
ES2729490T3
(es)
*
|
2014-10-08 |
2019-11-04 |
Ucb Biopharma Sprl |
Derivados de isoindolina
|
|
LT3221306T
(lt)
*
|
2014-11-20 |
2020-03-10 |
Merck Patent Gmbh |
Heteroarilo junginiai, kaip irak inhibitoriai ir jų panaudojimas
|
|
TWI698436B
(zh)
*
|
2014-12-30 |
2020-07-11 |
美商佛瑪治療公司 |
作為泛素特異性蛋白酶７抑制劑之吡咯并及吡唑并嘧啶
|
|
MD3316969T2
(ro)
|
2015-07-02 |
2022-07-31 |
Janssen Sciences Ireland Unlimited Co |
Compuși antibacterieni
|
|
CA3001768C
(en)
|
2015-11-02 |
2022-12-13 |
Janssen Pharmaceutica Nv |
[1,2,4]triazolo[1,5-a]pyrimidin-7-yl compound
|
|
RS63359B1
(sr)
*
|
2015-11-06 |
2022-07-29 |
Incyte Corp |
Heterociklična jedinjenja kao inhibitori pi3k-gama
|
|
US10323038B2
(en)
|
2015-11-20 |
2019-06-18 |
Abide Therapeutics, Inc. |
Pyrazole compounds and methods of making and using same
|
|
WO2017087858A1
(en)
|
2015-11-20 |
2017-05-26 |
Abide Therapeutics, Inc. |
Pyrazole compounds and methods of making and using same
|
|
WO2017091818A1
(en)
|
2015-11-25 |
2017-06-01 |
Lieber Institute For Brain Development |
Comt inhibiting methods and compositions
|
|
WO2017106254A1
(en)
|
2015-12-18 |
2017-06-22 |
Merck Sharp & Dohme Corp. |
Glycosidase inhibitors and uses thereof
|
|
JP2019506430A
(ja)
|
2016-02-25 |
2019-03-07 |
エースニューロン・ソシエテ・アノニム |
グリコシダーゼ阻害剤
|
|
CN108884081B
(zh)
|
2016-02-25 |
2022-11-01 |
阿森纽荣股份公司 |
分离哌嗪衍生物的对映体的方法
|
|
JP6971999B2
(ja)
|
2016-02-25 |
2021-11-24 |
エースニューロン・ソシエテ・アノニム |
ピペラジン誘導体の酸付加塩
|
|
US11261183B2
(en)
|
2016-02-25 |
2022-03-01 |
Asceneuron Sa |
Sulfoximine glycosidase inhibitors
|
|
JP6994767B2
(ja)
|
2016-06-21 |
2022-01-14 |
エックス４ ファーマシューティカルズ， インコーポレイテッド |
Ｃｘｃｒ４阻害剤およびその使用
|
|
WO2018026371A1
(en)
|
2016-08-04 |
2018-02-08 |
Sunovion Pharmaceuticals Inc. |
Dual nav1.2/5ht2a inhibitors for treating cns disorders
|
|
EP3555087A1
(en)
|
2016-12-16 |
2019-10-23 |
Janssen Pharmaceutica NV |
Monocyclic oga inhibitor compounds
|
|
EP3555094A1
(en)
|
2016-12-16 |
2019-10-23 |
Janssen Pharmaceutica NV |
Bicyclic oga inhibitor compounds
|
|
TWI654978B
(zh)
|
2017-01-27 |
2019-04-01 |
美商美國禮來大藥廠 |
5－甲基－1,2,4－二唑－3－基化合物
|
|
AU2018216040A1
(en)
|
2017-02-06 |
2019-06-20 |
Janssen Pharmaceutica Nv |
OGA inhibitor compounds
|
|
AU2017400271B2
(en)
|
2017-02-24 |
2020-09-24 |
Asceneuron S.A. |
Sulfoximine glycosidase inhibitors
|
|
AU2018223192A1
(en)
|
2017-02-27 |
2019-06-20 |
Janssen Pharmaceutica Nv |
[1,2,4]-triazolo [1,5-a]-pyrimidinyl derivatives substituted with piperidine, morpholine or piperazine as OGA inhibitors
|
|
AR111693A1
(es)
|
2017-05-25 |
2019-08-07 |
Lilly Co Eli |
Compuestos de 5-metil-1,3,4-oxadiazol-2-ilo con actividad inhibitoria de oga
|
|
US11213525B2
(en)
|
2017-08-24 |
2022-01-04 |
Asceneuron Sa |
Linear glycosidase inhibitors
|
|
CA3110032A1
(en)
|
2018-08-22 |
2020-02-27 |
Asceneuron S.A. |
Succinate and fumarate acid addition salts of piperazine derivatives
|
|
US12016852B2
(en)
|
2018-08-22 |
2024-06-25 |
Asceneuron Sa |
Pyrrolidine glycosidase inhibitors
|
|
WO2020039029A1
(en)
|
2018-08-22 |
2020-02-27 |
Asceneuron S. A. |
Spiro compounds as glycosidase inhibitors
|
|
US20220143042A1
(en)
|
2019-02-22 |
2022-05-12 |
Asceneuron Sa |
Fused glycosidase inhibitors
|